107 related articles for article (PubMed ID: 25687677)
21. Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
Soga T; Sugimoto M; Honma M; Mori M; Igarashi K; Kashikura K; Ikeda S; Hirayama A; Yamamoto T; Yoshida H; Otsuka M; Tsuji S; Yatomi Y; Sakuragawa T; Watanabe H; Nihei K; Saito T; Kawata S; Suzuki H; Tomita M; Suematsu M
J Hepatol; 2011 Oct; 55(4):896-905. PubMed ID: 21334394
[TBL] [Abstract][Full Text] [Related]
22. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
23. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
25. Serum gamma-glutamyl transpeptidase: its clinical significance.
Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
[TBL] [Abstract][Full Text] [Related]
26. Biochemical changes in patients with combined chronic schistosomiasis and viral hepatitis C infections.
Fahim FA; Esmat AY; Hassan GK; Abdel-Bary A
Dis Markers; 2000; 16(3-4):111-8. PubMed ID: 11381190
[TBL] [Abstract][Full Text] [Related]
27. Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone.
Bauer K; Nowak P; Kleinkauf H
Eur J Biochem; 1981 Aug; 118(1):173-6. PubMed ID: 6116600
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats.
Zambotti-Villela L; Yamasaki SC; Villarroel JS; Alponti RF; Silveira PF
J Endocrinol Invest; 2008 Jun; 31(6):492-8. PubMed ID: 18591879
[TBL] [Abstract][Full Text] [Related]
29. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
30. Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis.
Babić Z; Bilić A; Babić D; Jagić V; Nikolić B; Sunić M
Wien Klin Wochenschr; 2003 May; 115(9):302-8. PubMed ID: 12793031
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease.
Elefsiniotis IS; Skounakis M; Vezali E; Pantazis KD; Petrocheilou A; Pirounaki M; Papatsibas G; Kontou-Kastellanou C; Moulakakis A
Eur J Gastroenterol Hepatol; 2006 May; 18(5):525-30. PubMed ID: 16607149
[TBL] [Abstract][Full Text] [Related]
32. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
[TBL] [Abstract][Full Text] [Related]
33. Activation and cytotoxicity of 2-alpha-aminoacyl prodrugs of methotrexate.
Smal MA; Dong Z; Cheung HT; Asano Y; Escoffier L; Costello M; Tattersall MH
Biochem Pharmacol; 1995 Feb; 49(4):567-74. PubMed ID: 7872963
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of serum fibrosis markers in diagnosis of infantile hepatitis syndrome].
Deng WL; Xiong H; Wang LL; Zou XB
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1029-32. PubMed ID: 25344185
[TBL] [Abstract][Full Text] [Related]
35. Liver cirrhosis and thyroid function: Friend or foe?
Vincken S; Reynaert H; Schiettecatte J; Kaufman L; Velkeniers B
Acta Clin Belg; 2017 Apr; 72(2):85-90. PubMed ID: 27553585
[TBL] [Abstract][Full Text] [Related]
36. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.
Jin BX; Zhang YH; Jin WJ; Sun XY; Qiao GF; Wei YY; Sun LB; Zhang WH; Li N
Sci Rep; 2015 Oct; 5():15026. PubMed ID: 26456479
[TBL] [Abstract][Full Text] [Related]
38. [Differential diagnosis of acute viral hepatitis and liver cirrhosis with severe activity (author's transl)].
Vido I; Rezai I
Med Klin; 1975 Oct; 70(40):1595-7. PubMed ID: 52826
[TBL] [Abstract][Full Text] [Related]
39. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
[TBL] [Abstract][Full Text] [Related]
40. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
